Floatz logo

Therapeutic Asset Ratings

234 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
5-ala
Glioblastoma
Alpheus Medical, Inc.P3B (58)
Chloroquine
Glioblastoma
Maastricht Radiation OncologyP3B (58)
FLUOROURACILUM
Glioblastoma
Leaf Vertical Inc.P3B (58)
Dasatinib
Glioblastoma
AHS Cancer Control AlbertaP2B (58)
Metformin
Glioblastoma
Weill Medical College of Cornell UniversityP2B (58)
Polyiclc
Glioblastoma
Jonsson Comprehensive Cancer CenterP2B (58)
azd1390
Glioblastoma
Children's Oncology GroupP2/3B (58)
Disulfiram
Glioblastoma
Olympion Medical CenterP2/3B (58)
Tinostamustine
Glioblastoma
Mundipharma Research LimitedP2/3B (58)
Veliparib
Glioblastoma
National Cancer Institute (NCI)P2/3B (58)
Temsirolimus
Glioblastoma
Nader SanaiP2B (57)
Copper
Glioblastoma
Olympion Medical CenterP2/3B (57)
Dabrafenib
Glioblastoma
National Cancer Institute (NCI)P4B (56)
Abemaciclib
Glioblastoma
Tango Therapeutics, Inc.P2B (56)
Cetuximab
Glioblastoma
University of MiamiP2B (56)
FIBROMUN
Glioblastoma
Philogen S.p.A.P2B (56)
Fluciclovine
Glioblastoma
Abramson Cancer Center at Penn MedicineP2B (56)
gw786034
Glioblastoma
Center Trials & TreatmentP2B (56)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Glioblastoma
National Cancer Institute (NCI)P2B (56)
Letrozole
Glioblastoma
Nationwide Children's HospitalP2B (56)
LEUPROLIDE
Glioblastoma
Nationwide Children's HospitalP2B (56)
Olaparib
Glioblastoma
Fundación de investigación HMP2B (56)
Palbociclib
Glioblastoma
AHS Cancer Control AlbertaP2B (56)
Ribociclib
Glioblastoma
Nationwide Children's HospitalP2B (56)
Selinexor
Glioblastoma
National Cancer Institute (NCI)P2B (56)
Showing 26 to 50 of 234 assets
PreviousPage 2 of 10Next